Correlation Between Nuvectis Pharma and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Nuvectis Pharma and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Recursion Pharmaceuticals.
Diversification Opportunities for Nuvectis Pharma and Recursion Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Nuvectis and Recursion is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Recursion Pharmaceuticals
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 0.83 times more return on investment than Recursion Pharmaceuticals. However, Nuvectis Pharma is 1.2 times less risky than Recursion Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 661.00 in Nuvectis Pharma on November 6, 2024 and sell it today you would earn a total of 15.00 from holding Nuvectis Pharma or generate 2.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Nuvectis Pharma |
| Recursion Pharmaceuticals |
Nuvectis Pharma and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Recursion Pharmaceuticals
The main advantage of trading using opposite Nuvectis Pharma and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |